Avoro Capital Advisors LLC

13F Holdings History for AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

Symbol: FOLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Ownership: 20.5M shares
Security Ownership: 6.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Avoro Capital Advisors LLC ownership in AMICUS THERAPEUTICS, INC. Common Stock, par value $0.01 per share (FOLD)

2025-05-15 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 20.5M shares of AMICUS THERAPEUTICS, INC. Common Stock, par value $0.01 per share (FOLD). This represents 6.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Avoro Capital Advisors LLC	6.7%		$133M	20.5M			$6.48	13G/A	3/31/2025	15 May 2025 09:30:38

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		1.81%	-0.25%	$103M	18M	-2,500,000	-12.2%	$5.73	Q2 2025
3/31/2025		2.61%	-0.34%	$167M	20.5M	-2,675,000		$8.16	Q1 2025
12/31/2024		3.09%		$218M	23.2M			$9.42	Q4 2024
9/30/2024		3.61%	-0.66%	$248M	23.2M	-4,225,000	-15.4%	$10.68	Q3 2024
6/30/2024		3.62%		$272M	27.4M			$9.92	Q2 2024
3/31/2024		3.76%		$323M	27.4M			$11.78	Q1 2024
12/31/2023		5.37%		$389M	27.4M			$14.19	Q4 2023
9/30/2023		5.2%		$333M	27.4M			$12.16	Q3 2023
6/30/2023		4.67%	+0.02%	$344M	27.4M	+100,000	+0.37%	$12.56	Q2 2023
3/31/2023		4.49%	+0.08%	$303M	27.3M	+500,000	+1.87%	$11.09	Q1 2023
12/31/2022		4.89%		$327M	26.8M			$12.21	Q4 2022
9/30/2022		5.17%		$280M	26.8M			$10.44	Q3 2022
6/30/2022		5.69%	+1.34%	$288M	26.8M	+6,300,000	+30.7%	$10.74	Q2 2022
3/31/2022		3.54%	+0.35%	$194M	20.5M	+2,000,000	+10.8%	$9.47	Q1 2022
12/31/2021		3.64%	+0.16%	$214M	18.5M	+820,727	+4.64%	$11.55	Q4 2021
9/30/2021		2.65%	+0.87%	$169M	17.7M	+5,229,273	+42%	$9.55	Q3 2021
6/30/2021		2.09%	+0.03%	$120M	12.5M	+200,000	+1.63%	$9.64	Q2 2021
3/31/2021		2.09%	+0.55%	$121M	12.3M	+3,250,000	+36.1%	$9.88	Q1 2021
12/31/2020		3.58%	-0.74%	$208M	9M	-1,850,000	-17.1%	$23.09	Q4 2020
9/30/2020		2.18%	-0.03%	$153M	10.9M	-150,000	-1.36%	$14.12	Q3 2020
6/30/2020		3.28%	+0.01%	$166M	11M	+50,000	+0.46%	$15.08	Q2 2020
3/31/2020		3.42%	-0.08%	$101M	11M	-250,000	-2.23%	$9.24	Q1 2020
12/31/2019		3.2%	+0.03%	$109M	11.2M	+100,000	+0.9%	$9.74	Q4 2019
9/30/2019		3.71%	+0.37%	$89M	11.1M	+1,100,000	+11%	$8.02	Q3 2019
6/30/2019		4.31%	+0.22%	$125M	10M	+500,000	+5.26%	$12.48	Q2 2019
3/31/2019		5.59%	-0.37%	$129M	9.5M	-625,000	-6.17%	$13.60	Q1 2019
12/31/2018		5.8%	+0.45%	$97M	10.1M	+791,868	+8.48%	$9.58	Q4 2018
9/30/2018		5.18%	-0.02%	$113M	9.33M	-36,018	-0.38%	$12.09	Q3 2018
6/30/2018		5.63%	-0.08%	$146M	9.37M	-136,297	-1.43%	$15.62	Q2 2018
6/30/2018	call		-0.18%	$0	0	-2,350,100	-100%	^*	Q2 2018
3/31/2018		6.83%	+1.61%	$143M	9.51M	+2,242,325	+30.9%	$15.04	Q1 2018
3/31/2018	call	0.18%	+0.06%	$3.76M	2.35M	+850,100	+56.7%	$1.60^*	Q1 2018
12/31/2017		6.77%	+0.77%	$105M	7.26M	+826,000	+12.8%	$14.39	Q4 2017
12/31/2017	call	0.11%	-0.11%	$1.76M	1.5M	-1,500,000	-50%	$1.18^*	Q4 2017
9/30/2017		7.53%	+0.59%	$97.1M	6.44M	+506,166	+8.53%	$15.08	Q3 2017
9/30/2017	call	0.65%	+0.6%	$8.4M	3M	+2,750,000	+1100%	$2.80^*	Q3 2017
6/30/2017		7.54%	+1.38%	$59.7M	5.93M	+1,083,379	+22.3%	$10.07	Q2 2017
6/30/2017	call	0.07%		$532K	250K			$2.13^*	Q2 2017
3/31/2017		4.42%	+0.76%	$34.6M	4.85M	+830,000	+20.7%	$7.13	Q1 2017
3/31/2017	call	0.03%	+0.03%	$206K	250K	+250,000	NEW	$0.82^*	Q1 2017
12/31/2016		4.03%	+0.33%	$20M	4.02M	+327,720	+8.88%	$4.97	Q4 2016
9/30/2016		4.79%	-0.01%	$27.3M	3.69M	-8,808	-0.24%	$7.40	Q3 2016
6/30/2016		4.49%	+0.33%	$20.2M	3.7M	+274,561	+8.02%	$5.46	Q2 2016
3/31/2016		10.1%	-0.27%	$28.9M	3.42M	-91,507	-2.6%	$8.45	Q1 2016
12/31/2015		11.7%	-2.45%	$34.1M	3.52M	-734,588	-17.3%	$9.70	Q4 2015
9/30/2015		15.5%	-1.24%	$59.5M	4.25M	-340,000	-7.41%	$13.99	Q3 2015
6/30/2015		17.9%	+1.48%	$65M	4.59M	+378,800	+8.99%	$14.15	Q2 2015
3/31/2015		18.8%	+6.2%	$45.8M	4.21M	+1,387,214	+49.1%	$10.88	Q1 2015
12/31/2014		16.6%		$23.5M	2.82M			$8.32	Q4 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.